| Funding Opportunity ID: |
322019 |
| Opportunity Number: |
HR001120S0004 |
| Opportunity Title: |
Bridging the Gap Plus (BGPlus) |
| Opportunity Category: |
Discretionary |
| Opportunity Category Explanation: |
|
| Funding Instrument Type: |
Cooperative Agreement
Grant
Other
Procurement Contract |
| Category of Funding Activity: |
Science and Technology and other Research and Development |
| Category Explanation: |
|
| CFDA Number(s): |
12.910 |
| Eligible Applicants: |
Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: |
All responsible sources capable of satisfying the Government's needs may submit a proposal that shall be considered by DARPA. See the Eligibility Information section of the BAA for more information. |
| Agency Code: |
DOD-DARPA-BTO |
| Agency Name: |
Department of Defense
DARPA – Biological Technologies Office |
| Posted Date: |
Oct 30, 2019 |
| Close Date: |
Jan 22, 2020 See Full Announcement for details. |
| Last Updated Date: |
Oct 30, 2019 |
| Award Ceiling: |
$0 |
| Award Floor: |
$0 |
| Estimated Total Program Funding: |
|
| Expected Number of Awards: |
|
| Description: |
The Bridging the Gap Plus (BG+) program will develop new approaches to treating spinal cord injury by developing systems that address acute injury stabilization regenerative therapy as well as chronic functional restoration. |
| Version: |
1 |
